Editorial: Btk-friend or foe in autoimmune diseases?

Journal of Leukocyte Biology

Volumn 94, Issue 5, 2013, Pages 859-861

  Barral, Patricia ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Systemic lupus erythematosus; Toll like receptor; X linked immunodeficiency

Indexed keywords

ANTINUCLEAR ANTIBODY; BRUTON TYROSINE KINASE; CD5 ANTIGEN; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN M; INTERLEUKIN 10; MYELOID DIFFERENTIATION FACTOR 88; THYMUS INDEPENDENT ANTIGEN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CYTOKINE RELEASE; EDITORIAL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

SYSTEMIC LUPUS ERYTHEMATOSUS; TOLL-LIKE RECEPTOR; X-LINKED IMMUNODEFICIENCY;

ANIMALS; B-LYMPHOCYTES; FEMALE; LYMPHOCYTE ACTIVATION; MALE; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, B-CELL; RHEUMATOID FACTOR; TOLL-LIKE RECEPTORS;

EID: 84887008119     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0513279     Document Type: Editorial

References (11)

1. Nündel, K., Busto, P., Debatis, M., Marshak-Rothstein, A. (2013) The roll of Bruton's tyrosine kinase in the development and BCR/TLR-dependent activation of AM14 rheumatoid factor B cells. J. Leukoc. Biol. 94, 30.
2. Marshak-Rothstein, A. (2006) Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6, 823-835.
3. Khan, W. N., Alt, F. W., Gerstein, R. M., Ma-lynn, B. A., Larsson, I., Rathbun, G., David-son, L., Müller, S., Kantor, A. B., Herzen-berg, L. A. (1995) Defective B cell development and function in Btk-deficient mice. Immunity 3, 283-299.
4. Halcomb, K. E., Musuka, S., Gutierrez, T., Wright, H. L., Satterthwaite, A. B. (2008) Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells. Mol. Immunol. 46, 233-241.
5. Kanayama, N., Cascalho, M., Ohmori, H. (2005) Analysis of marginal zone B cell development in the mouse with limited B cell diversity: role of the antigen receptor signals in the recruitment of B cells to the marginal zone. J. Immunol. 174, 1438-1445.
6. Martin, F., Kearney, J. F. (2000) Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and Btk. Immunity 12, 39-49.
7. Steinberg, E. B., Santoro, T. J., Chused, T. M., Smathers, P. A., Steinberg, A. D. (1983) Studies of congenic MRL-Ipr/Ipr.xid mice. J. Immunol. 131, 2789-2795.
8. Honigberg, L. A., Smith, A. M., Sirisawad, M., Verner, E., Loury, D., Chang, B., Li, S., Pan, Z., Thamm, D. H., Miller, R. A., Buggy, J. J. (2010) The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc. Natl. Acad. Sci. USA 107, 13075-13080.
9. Kil, L. P., de Bruijn, M. J., van Nimwegen, M., Corneth, O. B., van Hamburg, J. P., Dingjan, G. M., Thaiss, F., Rimmelzwaan, G. F., Elewaut, D., Delsing, D., van Loo, P. F., Hendriks, R. W. (2012) Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. Blood 119, 3744-3756.
10. Schmidt, N. W., Thieu, V. T., Mann, B. A., Ahyi, A. N., Kaplan, M. H. (2006) Bruton's tyrosine kinase is required for TLR-induced IL-10 production. J. Immunol. 177, 7203-7210.
11. Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A., Shlomchik, M. J. (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25, 417-428.